Khondaker Miraz Rahman, PhD

School of Cancer and Pharmaceutical Sciences, King’s College London, United Kingdom

N/A

Poster(s):

• 1311 - Targeted Degradation of NF-κB RelA/p65 by PBD-Based PROTACs as a Novel Therapeutic Strategy in Chronic Lymphocytic Leukaemia